This training offers health care providers strategies and tools to care for adults with intellectual and developmental disabilities (IDD) who have challenging behavior or mental health concerns. The training includes approaches for patients who have communication barriers and presents some common physical health conditions that can lead to challenging behavior as well as other causes of challenging behavior, such as environmental or sensory issues. The modules also outline an approach for evaluating psychiatric symptoms, a review of non-pharmacological treatment options, and best practice criteria for using psychotropic medications for adults with IDD.
This training is not mandatory, but clinical rationale may be required to determine TennCare coverage of psychotropic medications for people with IDD.
If you have questions, comments or concerns regarding the content of this training series, please contact the Bureau of TennCare at: email@example.com
This enduring material received no commercial support.
The content of this material was reviewed in August, 2018.
By the completion of the training, physicians and other prescribers should be able to:
- Name 3 key elements in communicating with people with IDD.
- List 2 features for each of the levels of ID: mild, moderate, severe and profound.
- List 2 evidence-based tools from each of the sections of the IDD Toolkit: general issues, physical health issues, health watch tables and behavioral and mental health issues.
- Identify 3 physical health problems that may present as challenging behavior or psychiatric conditions.
- Outline the approach to a patient presenting with challenging behavior and 2 tools which provide a framework to assist with diagnosis.
- Discuss how autism spectrum disorder might be misdiagnosed as a psychotic disorder.
- Describe briefly the role for psychotropic medications in the treatment of adults with IDD.
- Describe briefly the role for non-pharmacologic treatments for challenging behavior in adults with IDD.
Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vanderbilt University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The release date for this enduring material is September 1, 2015. Credit expires on December 31, 2018. This enduring material received no commercial support.
After participating in this educational activity, learners should be able to:
- Discuss approaches for understanding and diagnosing underlying mental health issues for individuals with intellectual and developmental disabilities.
- Describe three underlying medical issues that may present as challenging behaviors or mental health issues in patients with intellectual and developmental disabilities.
- Describe strategies for communicating with patients with IDD, including those who are minimally verbal.
- Identify criteria for appropriate prescription of psychotropic drugs, as well as strategies for non-pharmacologic interventions.
- List two evidence-based tools from each of the sections of the IDD Toolkit: general issues, physical health issues, health watch tables, and behavioral and mental health issues.
Vanderbilt University School of Medicine is approved by the American Psychological Association to sponsor continuing education for psychologists. Vanderbilt University School of Medicine maintains responsibility for this program and its content.
Vanderbilt University School of Medicine designates this educational activity for 1.5 CE credits toward the continuing educational of psychologists. No partial credit may be awarded.
Instructional level: Intermediate